In a market were Pharmacuetical companies are running out of time on their patents, Columbia Labs has created a product and will hold its patent until 2018. This patent is for a new drug Crinone 8%...
Read complete stock pick on CBRX
© 2009 UpDown. All Rights Reserved.
Make a suggestion for this page
Suggestion
Data powered by QuoteMedia (Terms of Use). Data delayed 15 minutes unless otherwise indicated.